Japan To Shut Borders To Travelers From Flu-Outbreak Nations
This article was originally published in PharmAsia News
Health authorities plan to shut Japan's borders to travelers who attempt to arrive from countries incurring an influenza outbreak. The authorities, who fear 640,000 deaths if a new flu strain takes hold in Japan, say they will make anti-flu drugs such as Roche's Tamiflu (oseltamivir phosphate) available to Japanese embassies in outbreak countries and use its Self-Defense Forces to bring home non-infected Japanese from infected countries. Airlines with direct routes between an outbreak country and Japan are being asked to suspend operations if infected travelers could transport the flu to Japan. (Click here for more
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.